+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Etanercept"

Autoimmune Drugs - Global Strategic Business Report - Product Thumbnail Image

Autoimmune Drugs - Global Strategic Business Report

  • Report
  • July 2026
  • 287 Pages
  • Global
From
From
From
Rheumatology Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Rheumatology Therapeutics - Global Strategic Business Report

  • Report
  • July 2026
  • 196 Pages
  • Global
From
Autoimmune Monoclonal Antibody Market Report 2026 - Product Thumbnail Image

Autoimmune Monoclonal Antibody Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Psoriasis Market Report 2026 - Product Thumbnail Image

Psoriasis Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
From
From
From
Psoriasis Drugs Market - Product Thumbnail Image

Psoriasis Drugs Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
From
Loading Indicator

Etanercept is a biologic drug used to treat immune disorders such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It is a recombinant fusion protein that works by blocking the action of tumor necrosis factor (TNF), a protein involved in inflammation. Etanercept is administered by subcutaneous injection and is available in both brand name and generic forms. Etanercept is a widely used drug in the treatment of immune disorders, and is often prescribed in combination with other medications. It is generally well tolerated, with the most common side effects being injection site reactions, headache, and upper respiratory tract infections. The etanercept market is highly competitive, with several major players. These include Amgen, Pfizer, AbbVie, and Johnson & Johnson. Other companies in the market include Biogen, Merck, and Novartis. Show Less Read more